The urinary tract infection treatment Market size is projected to reach US$ 13.02 billion by 2031 from US$ 10.10 billion in 2023. The market is expected to register a CAGR of 3.2% in 2022–2031. Development of novel alternative treatments such as nutritional supplements for UTI are likely to remain key urinary tract infection treatment market trends.
Urinary Tract Infections (UTIs) occur when bacteria, mostly from the skin or rectum, enter the urethra and infect the urinary tract. Although several parts of the urinary tract can be affected, the most prevalent type of UTI is a bladder infection (cystitis). Kidney infection (pyelonephritis), on the other hand, is less common but more severe than bladder infections. Growing prevalence of UTIs increase the demand for its prevention and treatment therapies such as antibiotics.
Advancements in molecular diagnostics technologies such as remote patient monitoring, and artificial intelligence are expected to enhance the efficiency of diagnostic procedures. A majority of the industry players focus on the development and launch of advanced kits and equipment with an aim to improvise the process of home diagnostics. For instance, in February 2024, PathogenDx, launched its D3 Array-UTI test. This test is a multiplexed PCR test that is capable of detecting 26 different pathogens and 12 antibiotic resistance gene markers. The test results can help clinicians deliver rapid treatment for UTI. Additionally, the rising geriatric population is expected to bring an uptake in the demand for UTI treatments in the coming decade.
Increasing prevalence of UTI is one of the prominent factors driving the growth of the urinary tract infection treatment market. For instance, according to a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, UTIs accounts for an estimated 6 million physicians visits each year in the US. Propelling incidences of UTIs is a major driver of global urinary tract infection treatment market share.
R&D in UTI treatment is expected to offer lucrative growth opportunities for players in the global urinary tract infection treatment market. Further, in February 2020, a new antibiotic treatment for urinary and bacterial infections, developed by Venatorx Pharmaceuticals and Global Antibiotic Research & Development Partnership (GARDP) is under final review by the FDA. The treatment represents a significant advancement in treating complicated urinary tract infections and serious infections caused by highly resistant bacteria.
Key segments that contributed to the derivation of the urinary tract infection treatment market analysis are drug class, indication, and distribution channel.
The geographic scope of the urinary tract infection treatment Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the urinary tract infection treatment Market. The US is estimated to hold the largest share of the North America urinary tract infection treatment market. The growth in the US is estimated due to rising incidence of UTI, the rising development in the field of home diagnostics for UTI, and the presence of the startups offering treatments for UTI. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the Urinary Tract Infection Treatment Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Urinary Tract Infection Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 10.10 Billion |
| Market Size by 2031 | US$ 13.02 Billion |
| Global CAGR (2023 - 2031) | 3.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered |
By Drug Class
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Urinary Tract Infection Treatment Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Urinary Tract Infection Treatment Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The urinary tract infection treatment Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for urinary tract infection treatment and strategies:
The “Urinary Tract Infection Treatment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas: